• Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
  • Product mockup
1 9

The Purple Sky Store

Men's Columbia Soft Shell Jacket (Embroidered Purple Ribbon)

Men's Columbia Soft Shell Jacket (Embroidered Purple Ribbon)

$149.00 USD
$149.00 USD
Sale Sold out
Shipping calculated at checkout.
Color
Size
Columbia Weather Warrior Support Jacket

Tackle the elements with purpose in the Columbia Weather Warrior Support Jacket, a high-performance outerwear piece built for warmth, comfort, and resilience. Made from 100% polyester Nexegen contour-bonded soft shell material, this Columbia jacket is wind and water-resistant, making it an essential for outdoor adventures or daily wear. With zippered hand and chest pockets, adjustable cuff tabs, and a drawcord hem, it ensures a snug, tailored fit for any activity.

Beyond its functionality, this jacket supports a meaningful cause. 40% of all revenue from each Columbia Weather Warrior Support Jacket goes to Sky Foundation, a non-profit that funds pancreatic cancer research, helping you make a difference with every wear.

Authentic Columbia quality and durability
100% polyester Nexegen contour-bonded soft shell
100% polyester chamois touch tricot lining for added comfort
Wind and water-resistant for reliable weather protection
Zippered hand and chest pockets for secure storage
Adjustable cuff tabs and drawcord hem for a customized fit
Abrasion-resistant chin guard
View full details

Recent News

View all
  • Phase 1/2 Trial Launches for Innovative Pancreatic Cancer Immunotherapy

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

    Phase 1/2 Trial Launches for Innovative Pancrea...

    UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...

  • FDA Approves NALIRIFOX as First-Line Treatment for Metastatic Pancreatic Cancer

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

    FDA Approves NALIRIFOX as First-Line Treatment ...

    New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...

  • Immunotherapy for Pancreatic Ductal Adenocarcinoma: Barriers and Opportunities

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

    Immunotherapy for Pancreatic Ductal Adenocarcin...

    Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...

1 3
View all